Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-026522

Chief Financial Officer sold 725 shares at $25.57 ($18,538)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2022-04-28 Sale −725 $25.57 $18,538 53,252 D
Open-market sales · 725 sh · avg $25.57 · $18,538
Loading xslF345X03/doc4.xml…